Metraipolis › archive › dc_04573aa8b2bf
Novel risk scoring system for patients with metastatic castration-resistant prostate cancer treated with lutetium-177-PSMA-617 — Europe PMC PMID:42434975
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42434975
- DOI
- 10.1093/oncolo/oyag269
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-18T13:55:22.787Z
- SHA-256 of the archived text
faa5350d741c5a8db74384795a28b5dedd100b77ada62f5c8fbfc5e586066dff- Stable URL of this page
https://metraipolis.com/documento/dc_04573aa8b2bf
How to cite
Novel risk scoring system for patients with metastatic castration-resistant prostate cancer treated with lutetium-177-PSMA-617 — Europe PMC PMID:42434975 — Europe PMC (en), https://europepmc.org/article/MED/42434975 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04573aa8b2bf (Metraipolis archive dc_04573aa8b2bf, sha256 faa5350d741c5a8db74384795a28b5dedd100b77ada62f5c8fbfc5e586066dff)
BibTeX
@misc{dc04573aa8b2bf,
title = {Novel risk scoring system for patients with metastatic castration-resistant prostate cancer treated with lutetium-177-PSMA-617 — Europe PMC PMID:42434975},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42434975},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04573aa8b2bf; sha256 faa5350d741c5a8db74384795a28b5dedd100b77ada62f5c8fbfc5e586066dff},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42434975. Agents can read the archived copy with the MCP tool read_document.